Search
Pulmonx Corp
LUNGAdd to Watchlist
1.895USD
+0.015+0.80%
Market hours 10/06, 10:53（ET）
80.04MMarket Cap
LossP/E TTM
Pulmonx Corp (LUNG) Stock Price Target & Forecast
Analyst Rating
Based on 5 analysts giving stock ratings to Pulmonx Corp in the past month.
Buy
1 Strong Buy
2 Buy
2 Hold
0 Sell
0 Strong Sell
Target Price
3.400USD+85.79%
LUNG Analyst Recommendation Trends
In the current month, LUNG has received 2 Buy Ratings, 2 Hold Ratings, and 0 Sell Ratings. LUNG average Analyst price target in the last month is 3.400.
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
1
1
1
1
1
1
1
1
2
2
3
3
3
3
3
3
2
2
2
2
2
2
2
2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5
5
6
6
6
6
6
6
LUNG Analyst Rating for Peer Comparison
Updated: Oct 5, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Dexcom Inc
DXCM
13
12
4
0
0
29
Stryker Corp
SYK
11
13
5
0
0
29
Medtronic PLC
MDT
8
11
10
0
0
29
Abbott Laboratories
ABT
11
13
4
0
0
28
Medline Ord Shs Class A
MDLN
10
12
6
0
0
28
Zimmer Biomet Holdings Inc
ZBH
2
6
20
0
0
28
Guardant Health Inc
GH
12
13
2
0
0
27
Insulet Corp
PODD
10
12
5
0
0
27
Tandem Diabetes Care Inc
TNDM
5
8
10
0
0
23
Repligen Corp
RGEN
5
14
3
0
0
22
Financial Forecasting
Based on analysts' estimates, LUNG EPS is projected to reach -0.257 in FY2026Q3, following reported EPS of -0.237 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
-0.39
-0.33
-0.28
-0.26
-0.22
Actual
-0.25
-0.33
-0.24
--
--
Surprise
+35.78%
+0.24%
+15.23%
--
--
FAQs
What is Pulmonx Corp's expected revenue for the next quarter?
Pulmonx Corp's expected revenue is 21.94M.
What is Pulmonx Corp's price target?
Analysts forecast that Pulmonx Corp's price target is USD 3.40, with the highest forecast at USD 5.00 and the lowest forecast at USD 2.50.
How have Pulmonx CorpLUNG's recent earnings per share performed?
The market expectation was USD -0.24, while Pulmonx CorpLUNG's earnings per share (EPS) for the previous quarter was USD -0.33. EPS for the next quarter is expected at USD -0.26.
What is the analyst rating for Pulmonx Corp?
Based on the ratings of Pulmonx Corp's stock from 5 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.